Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-07-10

Clinical Trial Update: Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes

View source ↗

Summary

A completed clinical trial examining the role of incretin hormones in patients with liver disease, with and without diabetes, and its pathophysiological implica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Non Alcoholic Fatty Liver Disease, Type 2 Diabetes | Status: COMPLETED